Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) — Capital Reinvestment Ratio
Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has a Capital Reinvestment Ratio of 0.15x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥112.57 Million) in capital expenditures (CN¥16.66 Million). See Zhejiang Anglikang Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Capital Reinvestment Ratio (2014–2025)
This chart tracks Zhejiang Anglikang Pharmaceutical Co Ltd Class A's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025. For live market cap and broader valuation context, see 002940 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | CN¥244.13 Million | CN¥49.94 Million | ▼ -45.1% |
| 2024 | 0.37x | CN¥253.60 Million | CN¥94.46 Million | ▼ -17.5% |
| 2023 | 0.45x | CN¥276.91 Million | CN¥124.95 Million | ▲ +21.1% |
| 2022 | 0.37x | CN¥184.75 Million | CN¥68.82 Million | ▼ -15.7% |
| 2021 | 0.44x | CN¥197.65 Million | CN¥87.32 Million | ▼ -3.5% |
| 2020 | 0.46x | CN¥198.61 Million | CN¥90.96 Million | ▲ +29.4% |
| 2019 | 0.35x | CN¥213.49 Million | CN¥75.58 Million | ▼ -30.6% |
| 2018 | 0.51x | CN¥133.61 Million | CN¥68.17 Million | ▲ +80.5% |
| 2017 | 0.28x | CN¥193.77 Million | CN¥54.79 Million | ▲ +55.3% |
| 2016 | 0.18x | CN¥141.74 Million | CN¥25.81 Million | ▼ -28.1% |
| 2015 | 0.25x | CN¥138.59 Million | CN¥35.10 Million | ▼ -73.6% |
| 2014 | 0.96x | CN¥50.46 Million | CN¥48.48 Million | — |